Treatment escalation patterns to start biologics in refractory moderate juvenile dermatomyositis among members of the Childhood Arthritis and Rheumatology Research Alliance

• Asıl Yazarlar: Matthew A. Sherman (Yazar), Hanna Kim (Yazar), Katelyn Banschbach (Yazar), Amanda Brown (Yazar), Harry L. Gewanter (Yazar), Bianca Lang (Yazar), Megan Perron (Yazar), Angela Byun Robinson (Yazar), Jacob Spitznagle (Yazar), Cory Stingl (Yazar), Grant Syverson (Yazar), Heather O. Tory (Yazar), Charles H. Spencer (Yazar), Stacey E. Tarvin (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: BMC, 2023-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Background Despite new and better treatments for juvenile dermatomyositis (JDM), not all patients with moderate severity disease respond adequately to first-line therapy. Those with refractory disease remain at higher risk for disease and glucocorticoid-related complications. Biologic disea...